Cargando…
Anticoagulants for cancer-associated ischemic stroke
Patients with cancer-associated ischemic stroke pose similar clinical manifestations and image characteristics, mainly embolic infarction, as patients with atrial fibrillation do. D-dimer, a degraded product of fibrin polymer, is a useful indicator of hypercoagulability, which frequently increases i...
Autores principales: | Hsu, Jin-Yi, Liu, An-Bang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559024/ https://www.ncbi.nlm.nih.gov/pubmed/31258288 http://dx.doi.org/10.4103/tcmj.tcmj_55_19 |
Ejemplares similares
-
Anticoagulation for the Acute Management of Ischemic Stroke
por: Robinson, Austin A., et al.
Publicado: (2014) -
Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023) -
Anticoagulant therapy for ischemic stroke: A review of literature
por: Shahpouri, Mohammad Mehdi, et al.
Publicado: (2012) -
Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
por: Bang, Oh Young, et al.
Publicado: (2023) -
Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
por: Kim, Young Dae, et al.
Publicado: (2015)